FDA Warning Letter — Intas Pharmaceuticals Limited
The FDA took a Warning Letter action against Intas Pharmaceuticals Limited on November 21, 2023 (Ahmedabad, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Intas Pharmaceuticals Limited
- Date
- November 21, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Ahmedabad (India)